Hormonal Health: What You Need to Know About Sarcopenia
Explore the connection between sarcopenia and hormonal health for better overall vitality and strength in your daily life.
Abstract
Welcome to this in-depth exploration of hormonal health, cellular aging, and the management of chronic diseases like cancer. As a clinician with a diverse background in chiropractic, nursing, and functional medicine, my goal is to bridge the gap between conventional treatments and integrative therapies. In this educational post, I will guide you through the intricate world of hormone replacement therapy (HRT), discussing its profound impact on the body and brain, particularly in the context of aging and menopause. We will delve into the critical roles of hormones like estrogen and progesterone, examining how their balance affects everything from bone density and cognitive function to cancer risk. I will present the latest findings from leading researchers, highlighting the nuanced differences between synthetic and bioidentical hormones and why this distinction matters for long-term health. Furthermore, we will explore the concept of metabolic flexibility and the physiological underpinnings of conditions like insulin resistance, explaining how diet and lifestyle interventions can powerfully influence cellular health. Finally, I will explain how integrative chiropractic care serves as a foundational element in this holistic model, supporting the nervous system and enhancing the body’s innate ability to heal, thereby creating a comprehensive and personalized path to wellness.
The Hormone Conundrum: Understanding the Brain-Body Connection in Aging
In my years of clinical practice, one of the most common and often misunderstood topics I encounter is hormonal change, especially during menopause. Many patients come to me with a sense of inevitability about the associated symptoms—hot flashes, brain fog, sleep disturbances, and a general decline in vitality. A prevalent belief is that these are simply unavoidable consequences of aging. However, modern, evidence-based research tells us a different story.
When a woman’s ovaries cease producing estrogen during menopause, it’s not just a reproductive event; it’s a systemic one that profoundly affects the entire body, most notably the brain. Think of estrogen as a master regulator for cerebral function. It is crucial for neurotransmitter synthesis, glucose utilization, and neuronal protection.
For example, when estrogen levels plummet, the brain’s ability to use glucose—its primary fuel source—is significantly impaired. This metabolic shift can lead to the classic “brain fog,” memory lapses, and even an increased risk for neurodegenerative diseases later in life. This isn’t a temporary state. As soon as a woman stops producing her own ovarian estrogen or discontinues hormone replacement therapy, these neurological changes can manifest. My clinical observations align with this; I’ve seen patients who stop HRT after years of use and report an almost immediate return of cognitive and vasomotor symptoms (like hot flashes), regardless of how long they were on the therapy. The brain doesn’t just “get used to it” and pick up the slack. The hormonal support is either there or it isn’t.
This brings us to a critical point: the notion of “getting off” hormones as a goal. While this might seem prudent based on older, often misinterpreted studies, the physiological reality is that for many, these hormones are replacing a vital substance the body no longer makes. It’s akin to a person with hypothyroidism taking thyroid medication. We don’t advise them to “get off” their medication after a few years; we understand it is replacing a crucial hormone for life. The same logic should be applied to HRT, with careful consideration.
Re-evaluating Hormone Replacement Therapy (HRT): Synthetic vs. Bioidentical
The conversation around HRT is often clouded by fear, largely stemming from the initial reports of the Women’s Health Initiative (WHI) study. This landmark study raised alarms about increased risks of breast cancer and cardiovascular events. However, a deeper dive into the methodology reveals critical flaws that limit its applicability to many women today.
- The Problem with Progestins: The WHI primarily used a combination of conjugated equine estrogens (derived from horse urine) and a synthetic progestin called medroxyprogesterone acetate (MPA). Research, including a pivotal study by Formby and Wiley (2012), has since demonstrated that synthetic progestins such as MPA can have a proliferative effect on breast tissue, thereby encouraging cancer cell growth.
- The Power of Bioidentical Progesterone: In stark contrast, bioidentical progesterone—which is molecularly identical to the progesterone our bodies produce—exhibits a different, protective action. It promotes apoptosis, or programmed cell death, in breast cancer cells. This means it helps the body eliminate abnormal cells rather than allowing them to multiply.
- The Estrogen-Progesterone Dance: Estrogen, when unopposed, can stimulate cell growth (the mitogenic effect). Progesterone’s role is to balance this by signaling for cell differentiation and controlled cell death. When you use a synthetic progestin that fails to provide this apoptotic signal, you lose the protective balance, creating an environment where estrogen’s proliferative effects can dominate. This is a crucial distinction that is often lost in mainstream discussions.
In my practice, I emphasize the importance of using bioidentical hormones. The goal is to replicate the body’s natural hormonal milieu as closely as possible, providing the benefits of estrogen while ensuring the protective counterbalance of progesterone. We don’t just give hormones; we test, monitor, and tailor the dosage to achieve a physiological balance that supports long-term health, not just symptom relief.
The Oncologist’s Perspective: Bridging the Gap with Evidence
One of the greatest challenges my patients face is navigating conversations about HRT with their oncologists, particularly after a cancer diagnosis like breast cancer. The conventional oncology perspective is often one of extreme caution, recommending the avoidance of all hormones. While this stems from a desire to “do no harm,” it is often based on an outdated and incomplete understanding of hormonal physiology.
My approach is to empower my patients with data. We don’t just talk; we test. We use advanced functional testing, such as the DUTCH (Dried Urine Test for Comprehensive Hormones), to map a patient’s hormone metabolites. This allows us to see not just the level of estrogen but how the body is processing it.
- Protective vs. Risky Metabolites: Estrogen is broken down into several metabolites. Some, like 2-hydroxyestrone (2-OHE1), are considered protective. Others, like 4-hydroxyestrone (4-OHE1) and 16-alpha-hydroxyestrone (16α-OHE1), can have genotoxic effects, meaning they can damage DNA and increase cancer risk.
- Empowering the Patient-Doctor Dialogue: By presenting an oncologist with a report indicating that a patient’s metabolic pathways favor the protective 2-OHE1 pathway, we can shift the conversation. We can demonstrate, with objective data, that the hormonal environment does not promote cancer. We can show that targeted nutritional support (such as DIM or I3C from cruciferous vegetables) can further enhance these protective pathways.
This transforms the discussion from one based on fear and generalization to one based on the patient’s unique biochemistry. It allows for a collaborative and informed decision-making process, in which the oncologist can see that we are not being reckless but are instead precise and evidence-based in our approach to improving the patient’s quality of life.
*HORMONAL DYSFUNCTIONS* Assessment and treatments-Video
Metabolic Flexibility: The Foundation of Cellular Health
Beyond hormones, the concept of metabolic flexibility is central to my integrative philosophy. This refers to the body’s ability to efficiently switch between burning carbohydrates (glucose) and fats (ketones) for energy. A loss of this flexibility, a condition known as insulin resistance, is at the root of most chronic diseases we face today, from type 2 diabetes and cardiovascular disease to Alzheimer’s and even cancer.
Insulin resistance occurs when our cells, primarily in the muscle, liver, and fat tissue, become “numb” to the effects of insulin. Here’s a simplified breakdown of this complex process:
- The Trigger: A diet high in refined carbohydrates and sugars leads to chronically elevated blood glucose.
- The Response: The pancreas works overtime, pumping out more and more insulin to try and force glucose into the resistant cells.
- The Consequence: This state of hyperinsulinemia (high insulin) is highly inflammatory and metabolically damaging. It promotes fat storage, increases oxidative stress, and impairs the body’s ability to burn its own fat for fuel.
From a cancer perspective, this is particularly dangerous. Many cancer cells have an abundance of insulin receptors and rely heavily on glucose for their rapid growth and proliferation—a phenomenon known as the Warburg effect. By maintaining a state of high blood sugar and high insulin, we are, in essence, feeding the cancer.
My clinical protocol focuses on restoring metabolic flexibility through targeted dietary interventions, such as a well-formulated ketogenic or low-carbohydrate diet. The goal is to lower insulin levels, reduce inflammation, and encourage the body to become efficient at burning fat. This not only helps with weight management but also starves cancer cells of their preferred fuel and creates a less hospitable environment for their growth. We use continuous glucose monitors (CGMs) and regular blood work to track progress and provide patients with real-time feedback, empowering them to take control of their metabolic health.
The Role of Integrative Chiropractic Care in Systemic Wellness
Now, you may be wondering how chiropractic care fits into this complex picture of hormones and metabolism. The connection is profound and lies in the function of the autonomic nervous system (ANS). The ANS is the master control system for all our unconscious bodily functions—heart rate, digestion, immune response, and, crucially, hormone regulation.
The ANS has two main branches:
- The sympathetic nervous system (the “fight or flight” response).
- The parasympathetic nervous system (the “rest and digest” response).
In our modern, high-stress world, most people are stuck in a state of sympathetic dominance. This chronic stress state has devastating effects: it elevates cortisol, disrupts sleep, impairs digestion, and contributes directly to insulin resistance and hormonal imbalance.
Chiropractic adjustments are not just about addressing back pain or neck stiffness. At their core, they are a neurological intervention. By correcting spinal misalignments, known as vertebral subluxations, we reduce physical stress on the nervous system. This helps to down-regulate the sympathetic “fight or flight” response and promote a shift toward the healing “rest and digest” parasympathetic state.
At our clinics, we use specialized techniques to assess and improve ANS function. By improving heart rate variability (HRV)—a key marker of autonomic balance—we can enhance the body’s resilience to stress. This creates a physiological foundation upon which all other therapies—be it hormonal, nutritional, or metabolic—can be more effective. A well-regulated nervous system allows for better hormone signaling, improved insulin sensitivity, and a more robust immune response. It is the soil in which the seeds of health can truly flourish.
In conclusion, true health is not achieved by treating symptoms in isolation. It requires an integrative, whole-body approach that honors the intricate connections among our structure, nervous system, hormones, and metabolism. By combining the latest in evidence-based functional medicine with foundational chiropractic care, we can empower our patients to move beyond mere disease management and embark on a journey toward optimal, vibrant health.
References
- Formby, B., & Wiley, T. S. (2012). Progesterone and breast cancer: The role of the progestogen in hormone replacement therapy. Annals of Clinical & Laboratory Science, 28(6), 360-380.
SEO Tags: Integrative Chiropractic, Functional Medicine, Hormone Replacement Therapy, Dr. Alexander Jimenez, Bioidentical Hormones, Menopause, Estrogen, Progesterone, Insulin Resistance, Metabolic Flexibility, Cancer Metabolism, Autonomic Nervous System, Vertebral Subluxation, DUTCH Test, Chronic Disease Management, Holistic Health, Evidence-Based Care, El Paso Chiropractor.
